Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 February 2024
University of the Free State Logo

The University of the Free State (UFS) wishes to confirm that the following financial concessions have been made to enable students to register for the 2024 academic year:

 

  1. Students with confirmed NSFAS funding:
    • Students with a confirmed National Student Financial Aid Scheme (NSFAS) funding allocation for 2024 with a debt of R20 000 and less may register fully without making any payments.
    • First-time entering students (FTENS) with a confirmed NSFAS funding allocation for 2024 may register fully without any payments.
    • Students with a confirmed NSFAS funding allocation for 2024 with a debt of R30 000 and less may register provisionally and pay the required fees* for provisional registration.

       

  2. South African self-paying (NON-NSFAS) students:
    • SA students with a debt of up to R500 may register fully without making any payments.
    • SA students with a debt of up to R30 000 may register provisionally and pay the required fees* for provisional registration.

     

  3. FTENS not on UFS funded list:
    • Students who are not on the funded list but report that they have been approved on their portal must contact our Click to view document Financial Aid Offices urgently so that the university can escalate to NSFAS.

       

The university will have continuous engagement with the National Financial Aid Scheme (NSFAS) to resolve outstanding matters. The university’s Financial Working Group (FWG) will meet regularly to determine how it can best assist students taking into consideration the financial constraints of the university.

 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept